Amid the national opioid crisis, “Integrative Approaches to Pain Management” teaches health-care professionals non-pharmaceutical options.Continue reading
Category Archives: AZBio News
NFL Updates Concussion Protocol to Include Researcher’s “Fencing” Response
Response is sign of potential loss of consciousnessContinue reading
Arizona’s Bioscience Community Fills CEI for 2018 Kick Off
From her perch atop a ladder at the front of the room, AZBio president & CEO Joan Koerber-Walker shares AZBio’s key initiatives for 2018 and beyond with leaders from across our life science community.
It was standing room only as researchers, entrepreneurs, business leaders, investors, philanthropists, and patient advocates joined the AZBio Board to kick of AZBio’s 15th year of supporting Arizona’s life science community.Continue reading
Connect2STEM Breaks Record, UA Hosts Largest STEM Event in Phoenix
Wildcat Play Hospital, STEM bus, robotic Legos thrilled kids at family-friendly eventContinue reading
UA Part of $8.9M Collaborative Grant to Understand How Dangerous Virus `Hides’ to Attack Another Day
Dr. Felicia Goodrum and several of the nation’s most prominent human cytomegalovirus researchers have been awarded a five-year, $8.9 million collaborative grant to investigate how the virus lies dormant until it activates and poses life-threatening disease risk.Continue reading
Update – Proposed Continuing Resolution in the U.S. House and Medical Device Tax Suspension
The countdown clock is ticking on the status of federal funding and the end of the two-year suspension of the medical device tax. First payments on the medical device tax are due to be made in just 12 days.Continue reading
C-Path Welcomes Kay Holcombe to its Board of Directors
Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to its Board of Directors. Recently retired as Senior Vice President for Science Policy at the Biotechnology Innovation Organization (BIO), Ms. Holcombe brings to the Board her extensive experience in health care and regulatory policy, a history of collaboration with US regulatory agencies, and broad knowledge of government initiatives that affect the biotechnology and pharmaceutical industries.Continue reading
HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock
TUCSON, Ariz., Jan. 16, 2018 — HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced that it intends to offer and sell, subject to market and other conditions, 10,000,000 shares of its common stock in an underwritten public offering.Continue reading